Surevest, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History
Surevest, LLC
- $368 Million
- Q3 2022
A detailed history of Surevest, LLC transactions in Biohaven Pharmaceutical Holding CO Ltd. stock. As of the latest transaction made, Surevest, LLC holds 751 shares of BHVN stock, worth $38,301. This represents 0.03% of its overall portfolio holdings.
Number of Shares
751
Previous 1,166
35.59%
Holding current value
$38,301
Previous $170,000
32.94%
% of portfolio
0.03%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding BHVN
# of Institutions
11Shares Held
785KCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL710KShares$36.2 Million16.66% of portfolio
-
Eaton Vance Management Boston, MA35.9KShares$1.83 Million0.01% of portfolio
-
S. Muoio & Co. LLC New York, NY19KShares$967,9803.79% of portfolio
-
Agf Investments LLC Boston, MA11.6KShares$589,5600.16% of portfolio
-
Birchview Capital, LP Burlington, VT7.37KShares$375,6150.25% of portfolio
About Biohaven Pharmaceutical Holding Co Ltd.
- Ticker BHVN
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,645,000
- Market Cap $3.65B
- Description
- Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...